evodiamine derivatives (Valiant/Shenyang Pharmaceutical University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameevodiamine derivatives (Valiant/Shenyang Pharmaceutical University)
Drug Alias Nameantiproliferative agents (Valiant/Shenyang Pharmaceutical University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitotic G2 phase pathway modulatorsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesValiant Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A